Clinical Trial Update: A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating single and multiple oral doses of GLPG3970 in healthy participants and in psoriasis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• GLPG3970 (GLPG3970)

Snippet

Sponsor: Galapagos NV | Conditions: Healthy, Psoriasis | Phase 1 | Status: COMPLETED